UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

Report of Foreign Private Issuer

Pursuant to Rule 13a-16 or 15d-16

of the Securities Exchange Act of 1934

For the month of ~~February~~May 2025 ~~(Report No. 2)~~

Commission File Number: 001-40614

INTERCURE LTD.

(Translation of registrant’s name into English)

85 Medinat ha-Yehudim Street

Herzliya, 4676670, Israel

Tel: +972 77 460 5012

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ☐

On ~~February~~ 12May 1, 2025, InterCure Ltd. ~~(the~~issued ~~“Company”)~~a ~~announced~~press ~~that~~release titled ~~Mr.~~“InterCure ~~Ehud~~Announces ~~Barak~~FY2024 ~~will~~Results ~~step~~and ~~down~~Provides asQ1 ~~Chairman~~2025 ofUpdate: ~~the~~Revenue ~~Board, effective~~of ~~February~~NIS ~~13,~~239 ~~2025,~~Million and ~~will~~Adjusted beEBITDA ~~succeeded~~of byNIS ~~Mr. Alexander Rabinovich who has successfully led the Company as CEO for the past~~24 ~~five~~Million, ~~years.~~Strong ~~The~~Start ~~Company~~to ~~further~~2025” ~~announced~~a ~~the~~copy ~~completion~~ of ~~the~~which ~~financing~~is ~~previously~~furnished ~~reported on the Company’s Report on Form 6-K dated December 19, 2024. Attached hereto~~ as Exhibit 99.1 ~~and~~with ~~incorporated~~this ~~herein~~report isof ~~the~~foreign ~~Company’s~~private ~~press~~issuer ~~release~~on ~~titled “InterCure~~Form ~~Names Alex Rabinovich as Chairman Replacing Ehud Barak,” announcing such updates~~6-K.

Exhibit No. 99.1 Press Release issued by InterCure Ltd. on ~~February~~May 121, 2025, titled “InterCure ~~Names~~Announces ~~Alex~~FY2024 ~~Rabinovich~~Results asand ~~Chairman~~Provides ~~Replacing~~Q1 ~~Ehud~~2025 ~~Barak~~Update: Revenue of NIS 239 Million and Adjusted EBITDA of NIS 24 Million, Strong Start to 2025.”

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	INTERCURE LTD.
Date: February 12, 2025	/s/ Amos Cohen
Date: May 1, 2025	/s/ Amos Cohen
	Amos Cohen
	Chief Financial Officer

Filing Compare · Intercure Ltd.